机构:[1]Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.[2]Department of Hematology, Lymphoma and Myeloma Center, HMC Cancer Institute, The First Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, PR China.[3]Department of Lymphoma and Hematology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, PR China.[4]Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, PR China.[5]Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.[6]Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, Anhui, PR China.[7]Department of Hematology, Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, PR China.广东省中医院[8]Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, PR China.[9]Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, PR China.北京大学深圳医院深圳市康宁医院深圳医学信息中心[10]Department of Hematology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University), Shenzhen, PR China.深圳市康宁医院深圳市人民医院深圳医学信息中心[11]Cancer Center, Affiliated Hospital, Guangdong Medical University, Zhanjiang, Guangdong, PR China.[12]Department of Hematology, Huizhou Municipal Central Hospital, Huizhou, Guangdong, PR China.[13]Department of Medical Hematology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangdong gastrointestinal hospital, Guangzhou, Guangdong, PR China.中山大学附属第六医院[14]Department of Hematology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, PR China.[15]Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.[16]Department of Hematology, General Hospital of Southern Theater Command, PLA, Guangzhou, Guangdong, PR China.[17]The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, PR China.[18]Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.[19]Department of Hematology, The First Affiliated Hospital of Jinan university, Guangzhou, Guangdong, PR China.[20]Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
YL is supported by Sun Yat-sen University Start-Up Funding grant 201603, the
Program for Guangdong Introducing Innovative and Entrepreneurial Teams (2017ZT07S096) and National Natural Science Foundation of China grant 81873428.
HW is supported by National Natural Science Foundation of China grant 81700148
and Natural Science Foundation of Guangdong Province grant 2021A1515010093.
RPG acknowledges support from the National Institute of Health Research (NIHR)
Biomedical Research Center funding scheme. Y.L. and R.P.G. acknowledges support
funding from Ministry of Science and Technology of China (84000-51200002).
第一作者机构:[1]Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Hua Wang,Bi-bo Fu,Zhi-jun Wuxiao,et al.A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma[J].LEUKEMIA.2022,36(11):2724-2728.doi:10.1038/s41375-022-01679-x.
APA:
Hua Wang,Bi-bo Fu,Zhi-jun Wuxiao,Ya-jun Li,Li Huang...&Yang Liang.(2022).A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma.LEUKEMIA,36,(11)
MLA:
Hua Wang,et al."A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma".LEUKEMIA 36..11(2022):2724-2728